← All organizations
First clinical trial
Feb 1, 2021Last known activity
Oct 31, 2022
Timeline
2000s
- Jan 1, 2008
Tripos International— Acquired
- Jun 1, 2008
Certara— Founded
2010s
- Mar 13, 2012
Simcyp— Acquired
- Aug 13, 2013
Great Lakes Drug Development, Inc.— Acquired
- Apr 5, 2014
Synchrogenix— Acquired
- Dec 1, 2015
XenologiQ— Acquired
- Sep 7, 2016
d3 Medicine— Acquired
- Feb 1, 2018
BaseCase— Acquired
Drugs by trial phase (9 distinct, 8 trials)
Phase 3 (0 own, 2 via acquisition)
Phase 2 (1 own, 2 via acquisition)
Phase 1 (2 own, 2 via acquisition)
Subsidiaries (7 direct, 8 total across the full acquisition tree)
Recent trials (3)
- NCT05547321CollaboratorPhase 1Oct 31, 2022
- NCT04604548CollaboratorPhase 2Aug 9, 2021
- NCT04846036CollaboratorPhase 2Feb 1, 2021
Details
- Founded
- Princeton, NJ, US Jun 1, 2008
- Last known activity
- Oct 31, 2022